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ABS TRACT
Background and objectives: Emerging infectious diseases often originate in wildlife, making it important
to identify infectious agents in wild populations. It is widely acknowledged that wild animals are in-
completely sampled for infectious agents, especially in developing countries, but it is unclear how much
more sampling is needed, and where that effort should focus in terms of host species and geographic
locations. Here, we identify these gaps in primate parasites, many of which have already emerged as
threats to human health.
Methodology: We obtained primate host–parasite records and other variables from existing databases.
We then investigated sampling effort within primates relative to their geographic range size, and within
countries relative to their primate species richness. We used generalized linear models, controlling for
phylogenetic or spatial autocorrelation, to model variation in sampling effort across primates and
countries. Finally, we used species richness estimators to extrapolate parasite species richness.
Results: We found uneven sampling effort within all primate groups and continents. Sampling effort
among primates was influenced by their geographic range size and substrate use, with terrestrial spe-
cies receiving more sampling. Our parasite species richness estimates suggested that, among the best
sampled primates and countries, almost half of primate parasites remain to be sampled; for most
primate hosts, the situation is much worse.
Conclusions and implications: Sampling effort for primate parasites is uneven and low. The sobering
message is that we know little about even the best studied primates, and even less regarding the spatial
and temporal distribution of parasitism within species.
KEYWORDS : sampling events; parasite species richness; Global Mammal Parasite Database;
relative sampling effort
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INTRODUCTION
Many of the most devastating infectious diseases in
humans have origins in wildlife [1–3]. For example,
the global AIDS pandemic originated through
human contact with wild African primates [4] and
influenza viruses circulate among wild bird popula-
tions [5]. These are not only historical occurrences.
Recently, for example, rodents were identified as the
source of a hantavirus outbreak in Yosemite
National Park, USA [6] and a novel rhabdovirus
(Bas-Congo virus) of probable animal origin
emerged in the Democratic Republic of Congo [7].
As human populations continue to expand into new
areas and global changes in temperature and habitat
alter the distributions of wild animals, humans
around the world will have greater contact with wild-
life [8]. Thus, understanding which infectious agents
have the potential to spread from animals to
humans is crucial for preventing future human dis-
ease outbreaks. Here, we outline current gaps in our
knowledge of primate infectious diseases at phylo-
genetic and geographic scales. By doing so, we pro-
vide new directions for sampling wild primates and a
statistical framework to address this issue in other
groups.
The first step in predicting zoonotic disease risks
to humans is to identify the animal hosts of infec-
tious agents. This information provides several in-
sights. First, it gives information on the host range
and specificity of the infectious agent. Second, it
provides information on the geographic distribution
of the infectious agent in wildlife, which can be
compared with human population density. Finally,
knowing the hosts of an infectious agent also pro-
vides information on risks for host shifts to humans
[9, 10]. For example, a host living at high density is
likely to exhibit higher prevalence of the infectious
disease and to have more contact with humans or
domesticated animals.
Many efforts are being made to document and
collate information on wildlife and human diseases
(e.g. HealthMap [11], EID Event Database [2] and
Global Mammal Parasite Database (GMPD) [12]).
Unfortunately, large-scale analyses of this type have
revealed major variations in sampling effort among
hosts and geographic regions, with some species
and areas being sampled rarely or not at all [10, 13].
If we hope to use wildlife disease data to make re-
liable predictions about future risks to humans, we
need to increase sampling in potential hosts and
the areas in which they are found. However, before
we can do this, we need to identify gaps in our
knowledge of wildlife infectious diseases.
Here, we investigate gaps in our knowledge of
primate parasites. We chose primates because they
are our closest relatives, and partly as a conse-
quence, many of humanity’s biggest killers have
originated in wild primates (e.g. HIV [4]). In add-
ition, much is known about primate parasites. We
acknowledge at the outset, however, that many other
vertebrates have been sources of emerging
infectious diseases in humans, and are thus suitable
for extensions of the effort conducted here. We use
the word parasite in a general sense, referring to
both microparasites such as viruses, bacteria, fungi
and protozoa, and macroparasites such as hel-
minths and arthropods. To assess gaps in our under-
standing of primate parasites, we examined records
from the GMPD [12]—a large-scale compilation of
parasite records from wild mammals—and use
these data to quantify and model variation in
sampling effort.
METHODOLOGY
Data collection
We obtained host–parasite records from the
GMPD (accessed 15 October 2012; [12]), geographic
range maps from IUCN [14] and the dated consen-
sus phylogeny from ‘10kTrees’ version 3 [15]. For
consistency across our analyses, we only included
primate species found in both the range maps and
phylogeny, and that we could identify to the species
level using the taxonomy of Wilson and Reeder [16].
For analyses of geographical sampling gaps, we
obtained latitude and longitude coordinates for each
host–parasite record with locality data from the
GMPD.
For each primate species, we collated data on
adult body mass (g) from Jones et al. [17]. We also
defined the substrate use of each species as terres-
trial (>90% of time on ground), semi-terrestrial
(<90% but>50% of time on ground), semi-arboreal
(<90% but >50% of time in trees) or arboreal
(>90% of time in trees) using Nowak [18], and
treated this as a continuously varying character in
the analyses. For each country, we assembled data
on gross domestic product (GDP) per capita (USD),
land area (km2), and the number of airports from
Central Intelligence Agency [19] and Emerson et al.
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[20]. We estimated airport density (airport/km2) by
dividing the number of airports by the land area of
the country.
Overall, our dataset contained 228 primate spe-
cies from 89 countries. We located host–parasite
data for 166 of these species from 57 countries.
The remaining 62 species and 32 countries have
no records in the GMPD and were listed as
‘unsampled’ in our analyses. Our parasite data con-
tain 651 unique parasite species or genera with
non-zero prevalence in primates (87 arthropods,
50 bacteria, 6 fungi, 326 helminths, 115 protozoa
and 67 viruses). Our dataset also contains 46 unique
parasite species or genera that have been looked for
in primates but never found (these data are import-
ant for estimating sampling effort, see below). We
included all parasites when quantifying the relative
amount of sampling by species and country, even
those we could only identify to the generic level; for
species accumulation curves, however, we only
included parasites we could identify to species or
strain to avoid double counting parasite species.
This left us with 161 primate species and 502 para-
site species with non-zero prevalence in primates
(73 arthropods, 32 bacteria, 4 fungi, 242 helminths,
93 protozoa and 58 viruses) for these analyses. We
also excluded 22 ‘unsampled’ primates from our
models of variation in sampling effort among pri-
mate species because we were unable to locate life
history data for them.
Sampling effort
Our measure of sampling effort is the number of
sampling events for each primate. We define a
sampling event as one primate species being
sampled for one parasite species in one location
in one paper. The number of sampling events in a
paper depends on how the results were reported in
the paper, and hence how they were added to the
GMPD. For example, a paper reporting that Pan
troglodytes is infected by Ascaris lumbricoides repre-
sents one sampling event; a paper reporting that P.
troglodytes is infected by A. lumbricoides and SIVcpz
in Location A and Location B represents four
sampling events. This method assumes that each
sampling event represents equivalent research ef-
fort; however, some sampling events may represent
multiple years, multiple populations and/or mul-
tiple individuals, while others represent only one
individual sampled once. Other samples may be
counted multiple times, for example one fecal sam-
ple may reveal several parasites. However, in
general, we believe that our definition of sampling
events should give us a conservative estimate of
sampling effort. Note that we included sampling
events with zero prevalence for the parasite
sampled because these still represent valid
sampling effort.
In total, our host–parasite data consisted of 5459
sampling events, which we used to quantify relative
sampling of primate species. Of these sampling
events, 4067 have georeferenced localities in the
GMPD and thus we also used these to quantify rela-
tive sampling of geographic regions. As mentioned
above, we only included parasites we could identify
to species or strain for species accumulation curves,
leaving us with 3999 sampling events in these ana-
lyses. These criteria meant our species accumula-
tion curves only use around 75% of our sampling
events for some analyses, but they are necessary to
ensure that we are using the highest quality data in
the analyses of specific areas. It also further high-
lights the need for more research into primate para-
sites. We deposited all data in the Dryad repository:
doi:10.5061/dryad.510sb.
Analyses
Variation in sampling effort among primate
species
All else being equal, primates should be sampled in
proportion to their abundance, so we used ln(geo-
graphic range size) as a proxy for abundance and
assumed primates with the largest geographic range
sizes should be sampled more than primates with
small ranges. We estimated sampling relative
to geographic range size using the residuals from
a phylogenetic generalized least squares (PGLS)
model of ln(sampling events) against ln(geographic
range size), fitted using the R package caper [21]
(Appendix 1). We considered primates with posi-
tive residuals as being relatively better sampled
given their geographic range size than primates
with negative residuals, and displayed these results
on the phylogeny. We also expect great apes
(Hominoidea) to be better sampled than other
primates, so we tested this using phylogenetic
analysis of variance (ANOVA; Appendix 1).
Variation in sampling effort among geographic
regions
We assumed that countries should be sampled in
proportion to the number of primates found within
the country, i.e. countries with high primate species
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richness should be sampled more than countries
with low primate species richness. We therefore
estimated sampling relative to primate species rich-
ness within each country using the residuals from a
spatial generalized least squares (GLS) model of
ln(sampling events) against ln(primate species rich-
ness) using the R package nlme [22] (Supplementary
Data, Appendix 1). We considered countries with
positive residuals as relatively better sampled given
their primate species richness than countries with
negative residuals and displayed these results on a
world map.
Modeling variation in sampling effort among
primate species
We predicted that the following variables would
influence sampling effort among primate species:
(i) geographic range size (we expect primates with
larger geographic ranges to be sampled more often
than primates with smaller ranges); (ii) phylogenetic
distance from humans (medical research is likely to
focus on our closest relatives, thus we expect them
to be sampled more often); (iii) body size (small
species are easier to capture and so likely to be
sampled more than larger species) and (iv) sub-
strate use (terrestrial species are easier to sample
than arboreal species and thus should be sampled
more often). We therefore fit the following model:
Sampling events per primate
¼ f (geographic range size
þ phylogenetic distance from humans
þ substrate use+ body sizeÞ
ð1Þ
We fit PGLS models for the 205 primate species for
which we had data (including 40 ‘unsampled’ pri-
mates). All variables except substrate use were nat-
ural log transformed prior to analysis. We also used
caper [21] to estimate phylogenetic signal (i.e. l,
Supplementary Data, Appendix 1) in the number of
sampling events across primates. Phylogenetic sig-
nal is the tendency for related species to resemble
each other more than they resemble species drawn
at random from a phylogenetic tree [23]. High phylo-
genetic signal, i.e. l values close to 1, indicates that
closely related species have similar numbers of
sampling events, whereas low phylogenetic signal,
i.e. l values close to 0, indicates that the number of
sampling events varies randomly across the phyl-
ogeny. We acknowledge that many of our vari-
ables—such as sampling effort and geographic
range size—are not biological traits subject to nor-
mal evolutionary change. However, they may
still show phylogenetic non-independence, and l
enables quantification of that non-independence re-
gardless of which underlying process generates it.
Modeling geographic variation in sampling
effort
We predicted that the following variables would in-
fluence sampling effort among countries: (i) primate
species richness (countries with more primates are
likely to be sampled more often than countries with
fewer primates because there are more primates to
sample); (ii) GDP (we expect countries with a high
GDP to have more resources for disease monitoring
and hence to be sampled more often than countries
with a lower GDP) and (iii) airport density (countries
with more airports given their area are likely to be
easier to visit, and hence disease monitoring should
be more frequent). We therefore fit the following
model:
Sampling events per country
¼ f ðGDP + primate species richness
þ airport densityÞ
ð2Þ
We fit spatial GLS models for the 89 countries
that contain primates (including 32 ‘unsampled’
countries). All variables were natural log trans-
formed prior to analysis. Note that the results were
almost identical when using a spherical rather than
an exponential correlation structure, so we only
report the exponential correlation structure results.
Extrapolating parasite species richness for
primates and countries
We first used the R package vegan [24] to plot species
accumulation curves [25] of cumulative parasite
species richness against sampling events for each
primate species (N = 41) and country (N = 21) with
30 or more sampling events. To reduce the effects of
inter-sampling event heterogeneity on the shapes of
the curves, we used rarefaction (Supplementary
Data, Appendix 1) to produce smooth mean species
accumulation curves, with confidence intervals
2 standard deviations from the mean.
Next, we used the data from our curves to predict
parasite species richness for these 41 primates
and 21 countries. We used two nonparametric algo-
rithms, Chao2 and first-order Jackknife (Jackknife1),
which have been recommended in this context
[25–27] (Supplementary Data, Appendix 1). We also
estimated standard errors for our extrapolated para-
site species richness values based on references in
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Oksanen et al. [24], and used these to calculate
upper and lower bounds on extrapolated parasite
species richness. Finally, we plotted species accu-
mulation curves of cumulative parasite species rich-
ness for all primate species combined, first using all
parasites and then using arthropods, helminths,
protozoa and viruses separately. We did not use
bacteria and fungi as we had very few of these para-
sites in our dataset (bacteria = 32 species; fungi = 4
species).
We used R version 2.15.0 [28] for all the analyses
above.
RESULTS
Variation in sampling effort among primate
species
Sampling effort was unevenly distributed among pri-
mates and ranged from 0 (62 ‘unsampled’ species)
to 630 sampling events (P. troglodytes), with a mean
of 30.71 ± 4.970. We plotted sampling effort in rela-
tion to the primates’ geographic range sizes (Fig. 1
and Supplementary Fig. S1). As predicted, we found
that the Hominoidea (great apes) were relatively well
sampled in relation to their geographic range size
and were sampled significantly more than other pri-
mates (F1,225 = 12.01, P = 0.002). We also found
great heterogeneity in the degree of parasite
sampling across all other major groups of primates,
i.e. Old World monkeys (Cercopithecoidea), New
World monkeys (Platyrrhini) and strepsirrhines
(Strepsirrhini, i.e. lemurs and galagos).
Variation in sampling effort among geographic
regions
Sampling effort was also unevenly distributed geo-
graphically and ranged from 0 (32 ‘unsampled’
countries) to 416 sampling events (Uganda), with
a mean of 42.70 ± 9.131. Many countries were poorly
sampled in relation to their primate species richness
(Fig. 2), with particularly low levels of sampling in
parts of South East Asia (including China, Thailand,
Cambodia, Myanmar, Laos and Vietnam), Central
and Western Africa (including Sudan, Somalia,
Cercopithecoidea
Strepsirrhini
Platyrrhini
Hominoidea
Figure 1. Sampling effort for parasites across the primate phylogeny, assuming that primates should be sampled in proportion
to their geographic range size. Species names have been omitted for clarity (see Supplementary Fig. S1 for a larger version with
species names). Relative sampling effort was quantified using the residuals from a generalized linear model of ln(geographic
range size) against the number of sampling events for each primate species. Gray circles indicate primates with poor sampling
relative to their geographic range size (lower 25% of model residuals), black circles indicate primates with better sampling
relative to their geographic range size (upper 25% of model residuals).
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Angola, Zambia, Guinea and Ghana) and South
America (including Bolivia, Ecuador, Venezuela,
Guyana and Suriname).
Modeling variation in sampling effort among
primate species
Sampling effort for primate parasites covaried with
primate geographic range size, body mass and
substrate use: the most sampled primates tend to
have larger geographic ranges, to be larger in
body mass and to be more terrestrial (Table 1 and
Supplementary Table S1). We found no significant
effect of phylogenetic distance between humans and
primates, indicating that both our close relatives and
more distantly related species show evidence for
sampling gaps. Our overall model explained around
a third of the variation in sampling effort (r2 = 0.333),
most of which appears to relate to the geographic
range size and terrestriality of the primates (in single
predictor models, geographic range size: r2 = 0.175;
body size: r2 = 0.061; substrate use: r2 = 0.163).
The number of sampling events for primates
showed significant, but intermediate, levels of phylo-
genetic signal (N= 228, l= 0.589). This value was
significantly different from both l= 0 and l= 1
(P< 0.001), indicating moderate phylogenetic
non-independence.
Modeling geographic variation in
sampling effort
Predictably, sampling effort across countries
increased with primate species richness. However,
Low HighSampling relave to primate species richness
Figure 2. Sampling effort for parasites across the world, assuming that countries should be sampled in proportion to their
primate species richness. Relative sampling effort was quantified using the residuals from a generalized linear model of ln(pri-
mate species richness) against the number of sampling events for each country. The colors indicate whether countries are poorly
sampled (low; red) or better sampled (high; yellow) relative to their primate species richness.
Table 1. PGLS model for explaining variation in sampling effort among
primate species
Variable Slope ± SE t201
Geographic range size (km2) 0.347 ± 0.056 6.222***
Phylogenetic distance (My) 0.189 ± 0.729 0.260
Substrate use 0.864 ± 0.155 5.572***
Body size (g) 0.409 ± 0.158 2.597*
l = 0.322; r2 = 0.333. Phylogenetic distance is measured as phylogenetic distance from humans in millions of years.
Substrate use is a four-state-ordered variable ranging from fully terrestrial to fully arboreal, with more arboreal species
scored higher. *P< 0.05; ***P< 0.001.
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neither GDP nor airport density significantly pre-
dicted sampling effort (Table 2 and Supplementary
Table S2).
Extrapolating parasite species richness for
primates and countries
Figure 3 shows the parasite species accumulation
curve for all primates combined, and for arthropods,
helminths, protozoa and viruses. Across primates
and countries, most parasite species accumulation
curves were starting to show some downward curva-
ture, indicating a declining rate of parasite species
discovery, but in no cases had they approached an
asymptote. Interestingly, the different types of para-
sites accumulated at different rates, with arthropods
and helminths accumulating at a much faster rate
than protozoa and viruses (see slope differences in
Fig. 3). The parasite species accumulation curve for
P. troglodytes is shown in Supplementary Fig. S2.
Our estimates of parasite species richness using
Chao2 and Jackknife1 are shown in Supplementary
Tables S3–S5. Using Jackknife1, which appears to
give more reasonable values, across the 41 best
sampled primates, on average, we predict that there
should be between 38 and 79% more parasites than
currently recorded in the GMPD (Supplementary
Table S3). For countries, on average, we predict
that there should be between 29 and 40% more
parasites than currently recorded in the GMPD
(Supplementary Table S4). For all 161 primates in
our study combined, we should find between 685
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Figure 3. Parasite species accumulation curve for all 161 primates combined and all parasites (left-hand side). Parasite species
accumulation curve for all 161 primates combined and helminths, protozoa and viruses separately (right-hand side).
Parasites = cumulative parasite species richness. Arthropods = orange curve; helminths = blue curve, protozoa = green curve
and viruses = red curve. For each curve, the darker line shows the mean curve and the lighter shaded region shows 2 standard
deviations from the mean curve, each obtained from 1000 random permutations of the data. Note that the axes sizes are different
on the left- and right-hand plots.
Table 2. Spatial GLS model with an exponential correlation structure,
explaining variation in sampling effort among countries
Variable Slope ± SE t84
Primate species richness 1.241 ± 0.290 4.273***
GDP per capita (USD) 0.437 ± 0.246 1.778
Airport density (airport/km2) 3.559 ± 3.041 1.170
 = 1.938; GDP = gross domestic product; ***P< 0.001.
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and 713 parasites, i.e. between 36 and 42% more
parasites than the 502 parasites identified to species
level that are currently reported in the GMPD for
these 161 primates (Supplementary Table S5).
DISCUSSION
Variation in sampling effort among primate
species and geographic regions
Virtually every broadscale comparison of sampling
effort, whether sampling disease agents in epidemi-
ology or species in biodiversity studies, reveals bias
in what is sampled. In epidemiology, for example,
sampling may be highest for diseases with easily
detectable symptoms and for areas easily accessed
by medical personnel. Here, we showed that primate
parasites are also unevenly sampled across both pri-
mate species and space. This supports previous
studies of sampling gaps in primate parasites that
used an earlier version of the GMPD data [13], but
unlike previous studies, we also investigated the
drivers of sampling effort variation across primates
and geographic areas.
For our analyses of variation in sampling effort
among primate species, we predicted that our
closest relatives (chimpanzees, gorillas and
orangutans) would be relatively well sampled be-
cause a great deal of research has focused on these
species. We expected most other primate species to
be comparatively poorly sampled, except when they
are more terrestrial or larger in body mass. As pre-
dicted, chimpanzees, gorillas and orangutans were
generally better sampled. However, we found incred-
ible variation in sampling among all other major
primate groups, intermediate phylogenetic signal
in sampling effort and no significant relationship
between sampling effort and the phylogenetic dis-
tance from humans to the primate in question.
Instead, our models suggested that most variation
in sampling effort among primates can be explained
by the geographic range size and level of terrestriality
of the primates. Put more simply, the primates that
researchers sample most are the species they en-
counter most often, including those that are more
likely to be on the ground than in the trees. This is
also supported by the low sampling of nocturnal
primates.
However, our models only explained 30% of
the variation in sampling effort across primates,
indicating that we did not capture every explanation
for this variation. Some primates may be sampled
because they are already intensively studied for
infectious disease, with researchers building on
previous knowledge rather than starting from
scratch. Other species may be sampled thoroughly
because they live in frequently used and well-
equipped field sites. Some of the variation in
sampling may have more idiosyncratic explan-
ations; for example, the extensive sampling of some
Macaca species likely reflects their use in medical
research.
We also identified great heterogeneity in sampling
among countries, even among those in the same
region. We found particularly low sampling in parts
of South East Asia, Central and Western Africa, and
South America, and better sampling in Eastern
Africa and Brazil. However, the only variable in our
statistical models that predicted sampling effort
among countries was the primate species richness
of the country, with parasite sampling highest in
countries that have more primates to sample. We
expected that the GDP of the countries would also
positively affect sampling effort, but we found no
evidence for this in our analyses, possibly because
much of the research is not funded by the country in
which the research takes place. In fact, on average,
only 22% of tropical biological field station funding
comes from the host country [29]. Perhaps a better
predictor of sampling effort would be the number of
research stations in a country.
Our parasite species accumulation curves, for
both primate species and countries, were starting
to show some downward curvature, but in no cases
had they approached an asymptote. In these ana-
lyses, we only used species or countries with at least
30 sampling events. This indicates that, at least for
these fairly well-sampled primates and countries,
sampling is slowly approaching levels sufficient to
quantify parasite species richness. However, when
we extended these analyses to extrapolate parasite
species richness values, we found that even within
our best sampled primates and countries, we are
missing substantial parasite diversity. On average,
we predicted that 38–79% more parasite species
than currently reported in the GMPD should be
found in our best sampled primate species and
29–40% more parasite species than currently re-
ported in the GMPD should be found in our best
sampled countries. This emphasizes exactly how
poor our sampling is across all primates and
countries. The other primates and countries obvi-
ously represent even larger gaps in our knowledge.
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Sampling was also uneven across types of para-
sites; when we analyzed arthropods, helminths,
protozoa and viruses separately, we saw faster rates
of parasite accumulation in arthropods and hel-
minths but with little evidence for sufficient
sampling in these species. This is interesting given
that helminths make up 48% of the parasite species
in our study (arthropods = 33%; bacteria = 6%;
fungi = 0.8%; protozoa = 19% and viruses = 12%).
We were not able to fit species accumulation curves
to bacteria or fungi because we have so few bacteria
and fungi species in our dataset. Given the import-
ance of bacterial and fungal emerging diseases in
humans [2, 30], this lack of sampling in wild pri-
mates is of concern. Another concern is that al-
though viruses make up only 12% of the parasites
in our dataset, viruses arguably present the greatest
zoonotic disease threat to humans because their
fast rates of evolution will allow them to easily adapt
to new hosts [3, 5]. The relatively low number of
viruses probably reflects detection bias. Viruses are
very hard to detect, and even when detected prove
difficult to classify. Therefore, our results probably
grossly underestimate the number of viruses pre-
sent in primates.
Priorities for future research
Identifying parasite sampling gaps across primate
species and geographic regions is only the first step,
we need to find strategies to minimize these
sampling gaps if we are to predict which primate
infectious diseases may emerge in humans. One so-
lution is to set research priorities based on the
sampling gaps [13], for example, by focusing effort
and funding on relatively poorly sampled primate
species, arboreal primates, those with small geo-
graphic ranges or those found in relatively poorly
sampled regions of South East Asia, Central and
Western Africa, and South America.
Focusing on relatively poorly sampled primate
species and areas may improve our general under-
standing of primate parasites, but it is only one fac-
tor in predicting risk to humans. For example, hosts
are more likely to share parasites with their close
relatives than with more distant relatives [9, 10].
Thus, continuing to focus our sampling efforts on
parasites of our closest relatives (chimpanzees, gor-
illas and orangutans) may provide the greatest re-
turn in the case of risks to humans. This is
particularly important because we found that chim-
panzees are expected to have 33–50% more
parasites than currently found in the GMPD. In add-
ition, ecological similarities also influence parasite
sharing among primates, and humans share more
parasites with terrestrial than arboreal primate spe-
cies [9, 10]. As with sampling effort, this probably
reflects higher contact rates among humans and ter-
restrial primates compared with arboreal primates.
As a related issue, a host living at higher density is
expected to have higher prevalence of parasites and
may have more contact with human populations or
our domesticated animals, thus increasing
opportunities for host shifts to humans. The large
numbers of zoonotic emerging infectious diseases
with rodent or domesticated animal sources also
highlight the importance of rates of contact and host
density for disease emergence in humans [2, 3, 5].
CONCLUSIONS AND IMPLICATIONS
The aim of this study was to identify where the gaps
lie in our knowledge of primate parasites. We found
that sampling effort was unevenly distributed across
primate species and countries, and that the best
predictors of sampling effort were the geographic
range size or terrestriality of the primate species,
or the primate species richness of the country. We
also found that, according to our extrapolations of
parasite species richness, even our best sampled
primates and countries were still vastly under-
sampled, typically with only a quarter to two-thirds
of their parasites documented, and possibly even
less given that fungi and bacteria are so under-
represented in current records. This implies that if
we want to predict primate disease emergence in
humans, more sampling for parasites is needed
across all primate species and countries. This is es-
pecially important as human populations grow and
spread into new areas where they will encounter
more primates and consequently more diseases.
supplementary data
Supplementary data is available at EMPH online and
the Dryad repository: doi:10.5061/dryad.510sb.
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